FDA Investigator Thomas R Beilke

Thomas R Beilke has inspections in 1 countries as of 15 Jun 2023. Thomas R Beilke has collaborated with a combinined 2348 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
135
Last Inspection Date:
15 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Ademola O Daramola, Alexandra B Pitkin, Allen F Hall, Allison A Rodriguez, Alyson C Tanner, Amanda N Schaupp, Ana Djurdjevic, Anderson, Andrace Lde Yampert, Angela Shepas, Anita Narula, PhD, Annette Melendez, Arie C Menachem, Armando Chavez, MS, Babajide Michael Osunsanmi, Barbara J Rincon, Bichsa T Nguyen, Bichsa T Tran, Binh T Nguyen, Bowman, Brian P Putz, Burnsb, Bush, Carla J Lundi, Carr Sharpe, Caryn M Everly, Caryn M Mcnab, Cheron M Portee, Christina D Mello, Comyar Shoghi, Courtney N Long, Crystal Monroy, Cynthia J Lee, MS, David G Whitman, Diane Cvan Leeuwen, Dianiris C Ayala, Doan T Nguyen, PharmD, Dr. Monica D Cooper, Dustin R Abaonza, Finn A Slizza, Francisco, Frederick L Fricke, Garciam, Herminio C Francisco, James A Barreto, James D Hildreth, James E Bentson, James P Stumpff, James R Fleckenstein, James R Montero, Janet K White, Jennifer M Gogley, Jeremy Beber, Jeremy H Nguyen, Jocelyn E Massey, Joe X Phillips, Joey V Quitania, Jonathan R Campos, Joseph C Yen, Julian C Hanson, Karen A Wolnik, Kari M Johansen, Katherine E Jacobitz, Kelvin Cheung, Kevin T Gerrity, Kham Phommachanh, Kim Lthomas Cruse, Kimberly M Lichter, Kirsten S Tharp, Kirtida Patel, Lakecha N Lewis, Lanita F Kelley, Lata C Mathew, PhD, Laurissa S Flowers, Liming Zhang, Linda Galindo, Linda Thai, Linda Than, Lynette M Terry, Marcia B Williams, Margo Cl Jones, Marie T Falcone, Mark C Saale, Mary Ewilkerson Brinsko, Matthew J Johnson, Mendoza O Wallace, Michelle A Mash, Michelle J Hines, Michsa T Nguyen, Mihaly S Ligmond, Myra K Casey, Nancy E Byerly, Natalie J Ayoub, Natalie J Reese, Paquita F Segarra, Paul A Bonneau, Paul M Chefor, Paul M Kawamoto, Phal K Chhun, Rachel C Stanton, Randall N Johnson, Richmond K Yip, Robert S Sweeton, Robert T Lorenz, Ronda R Loyd Jones, Saied A Asbagh, Samson O Oluseye, Sandra S Saniga, Santiago Gallardo Johnson, Sara Jdent Acosta, Sarah A Hassas, Scott K Zika, Selene T Torres, Shaquenta Y Perkins, Sherri N Rohlf, MD, Sidney B Priesmeyer, Sonya L Karsik, Sparky L Bartee, Stanley B Eugene, BS, BME, Sundy Ven, Sunitha K Rajaram, PhD, Thao T Kwan, Theresa Kirkham (NMI), Timothy P Lafave, Tracey T Duong, Trudy R Papson, Uttaniti Limchumroon (Tom), Valerie L Whipp, Vickie L Anderson, Virgilio F Pacio, CSO, William J Leonard, Yumi J Hiramine, Yvette E Guillermo, Zachary A Bogorad, Zachary P Wachlarowicz

Thomas R Beilke's Documents

Publish Date Document Type Title
October, 2000 EIR Schonbrun, Myron MD Dba Damluji Research Center - EIR, 2000-10-02
September, 2001 EIR Jon A LeLevier MD - EIR, 2001-09-21
July, 2002 FDA 483 Response Kotha, Purushotham MD - Form 483R, 2002-08-05
August, 2011 FDA 483 Veridiam Swiss Screw Products LLC - Form 483, 2011-08-26
March, 2000 FDA 483 Allergy & Asthma Medical Grp. & Research Center A.P.C. - Form 483, 2000-03-17
February, 2002 EIR Lozier, Jeffrey R, MD - EIR, 2002-02-20
May, 2001 EIR Ramsdell, Joseph W Md - EIR, 2001-05-14
September, 2001 FDA 483 Jon A LeLevier MD - Form 483, 2001-09-21
September, 2000 FDA 483 WR-MCCR, LLC - Form 483, 2000-09-19
June, 2009 FDA 483 Pacira Pharmaceuticals, Inc. - Form 483, 2009-06-04
September, 2000 EIR WR-MCCR, LLC - EIR, 2000-09-19
May, 2001 FDA 483 Joseph W. Ramsdell, M.D. - Form 483, 2001-05-14
February, 2005 FDA 483 Coutts, Richard MD - Form 483, 2005-02-09
September, 2002 EIR Laboratory Corp of America - EIR, 2002-09-18
July, 2002 EIR Kotha, Purushotham MD - EIR, 2002-07-18
July, 2011 FDA 483 Zest Anchors LLC - Form 483, 2011-07-27
January, 2001 FDA 483 San Diego Fertility Center, Medical Group Inc - Form 483, 2001-01-17
February, 2005 EIR Coutts, Richard MD - EIR, 2005-02-09
April, 2009 FDA 483 Kipps, Thomas J., MD - Form 483, 2009-04-01
March, 2000 FDA 483 Response Meltzer, Eli O Md - Form 483R, 2000-03-24
January, 2001 EIR L. Michael Kettel, M.d. - EIR, 2001-01-17
April, 2010 FDA 483 Sall Research Medical Center, Inc. - Form 483, 2010-04-15
April, 2001 EIR Friedel, William E MD - EIR, 2001-04-03
June, 2000 FDA 483 Potkin, Steven G. Md - Form 483, 2000-06-07
September, 2000 FDA 483 Osteoporosis Medical Center - Form 483, 2000-09-01
July, 2006 EIR Thomas, Jay R MD PhD - EIR, 2006-07-28
July, 2002 FDA 483 Kotha, Purushotham MD - Form 483, 2002-07-18
March, 2000 EIR Meltzer, Eli O Md - EIR, 2000-03-17
September, 2000 EIR Maria W. Greenwald, MD - EIR, 2000-09-01
July, 2006 FDA 483 Thomas, Jay R MD PhD - Form 483, 2006-07-28
September, 2008 EIR Carlsbad Technology, Inc. - EIR, 2008-09-30
May, 2011 FDA 483 Medtronic Ablation Frontiers - Form 483, 2011-05-16
February, 2003 FDA 483 Press, Raymond I MD - Form 483, 2003-02-14
October, 2000 FDA 483 Schonbrun, Myron MD Dba Damluji Research Center - Form 483, 2000-10-02
June, 2005 FDA 483 Drosman, Steven R., MD - Form 483, 2005-06-07

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more